ecrin-mdr-crcClinical2022Colorectal CancerColorectal CancerObservationalhttps://newmdr.ecrin.org/Study/41480China8ECRIN MDRNot yet recruitingfalseEffect of dexmedetomidine on overall Survival in Colorectal Cancer PatientsInterventions: Dex Group:Intraoperative use of dexmedetomidine;Control Group:Intraoperative without dexmedetomidine Primary outcome(s): 3 years Survival Rate Study Design: Cohort study2022-08-1541480ChiCTR2200062405